Dr. Rafael Santana-Davila, MD
Claim this profileSeattle Cancer Care Alliance
Studies Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Cancer
Stage I
Stage II
HBcAb
2Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Rafael Santana-Davila, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Rafael Santana-Davila, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rafael Santana-Davila, MD has experience with
- Atezolizumab
- Biospecimen Collection
- Crizotinib
- Bomedemstat
- Trabedersen (OT-101)
- SurVaxM
Breakdown of trials Rafael Santana-Davila, MD has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rafael Santana-Davila, MD specialize in?
Rafael Santana-Davila, MD focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage II.
Is Rafael Santana-Davila, MD currently recruiting for clinical trials?
Yes, Rafael Santana-Davila, MD is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Rafael Santana-Davila, MD has studied deeply?
Yes, Rafael Santana-Davila, MD has studied treatments such as Atezolizumab, Biospecimen Collection, Crizotinib.
What is the best way to schedule an appointment with Rafael Santana-Davila, MD?
Apply for one of the trials that Rafael Santana-Davila, MD is conducting.
What is the office address of Rafael Santana-Davila, MD?
The office of Rafael Santana-Davila, MD is located at: Seattle Cancer Care Alliance, Seattle, Washington 98109 United States. This is the address for their practice at the Seattle Cancer Care Alliance.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.